Chemical Formula: C10H17N

Amantadine

C10H17N (151.1360922)

An antiviral that is used in the prophylactic or symptomatic treatment of influenza A. It is also used as an antiparkinsonian agent, to treat extrapyramidal reactions, and for postherpetic neuralgia. The mechanisms of its effects in movement disorders are not well understood but probably reflect an increase in synthesis and release of dopamine, with perhaps some inhibition of dopamine uptake. [PubChem] N - Nervous system > N04 - Anti-parkinson drugs > N04B - Dopaminergic agents > N04BB - Adamantane derivatives D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents Acquisition and generation of the data is financially supported in part by CREST/JST. COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent D002491 - Central Nervous System Agents > D000700 - Analgesics D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent C93038 - Cation Channel Blocker KEIO_ID A061 Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

2-Methyl-3-amylpyrrole

C10H17N (151.1360922)

2-Aminoadamantane

C10H17N (151.1360922)

2,3,4,5-Tetrahydro-6-(4-pentenyl)pyridine

C10H17N (151.1360922)

4-Deoxy-(2S,4S)-4-Hydroxy-2-(1,3-pentadienyl)piperidine

C10H17N (151.1360922)

Polyzonimine

C10H17N (151.1360922)

amantadine

C10H17N (151.1360922)

N - Nervous system > N04 - Anti-parkinson drugs > N04B - Dopaminergic agents > N04BB - Adamantane derivatives D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent D002491 - Central Nervous System Agents > D000700 - Analgesics D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent C93038 - Cation Channel Blocker Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; INTERNAL_ID 2670 INTERNAL_ID 2670; CONFIDENCE standard compound CONFIDENCE standard compound; INTERNAL_ID 4147 CONFIDENCE standard compound; EAWAG_UCHEM_ID 3124

Symmetrel

C10H17N (151.1360922)

Amantadine hydrochloride

C10H17N (151.1360922)

1-Aminoadamantane

C10H17N (151.1360922)

3-Amino-Beta-Pinene_major

C10H17N (151.1360922)

3-AMINO-beta-PINENE

C10H17N (151.1360922)

1-Chlor-6,6-dimethylhept-2-en-4-in

C10H17N (151.1360922)

3-AMINO-β-PINENE

C10H17N (151.1360922)

2-Adamantanamine

C10H17N (151.1360922)

2,2-bis(prop-2-enyl)pyrrolidine

C10H17N (151.1360922)

3-tert-Butyl-2,4-dimethylpyrrole

C10H17N (151.1360922)

Pyrrole, 4-isopropyl-2-propyl- (7CI)

C10H17N (151.1360922)

1-(1-BENZYLPYRROLIDIN-3-YL)-PIPERAZINE

C10H17N (151.1360922)

1-pyrrolidinocyclohexene

C10H17N (151.1360922)

1-Aminoadamantane-2,2,2′,2′,2″,2″-d6

C10H17N (151.1360922)

Citronellyl nitrile

C10H17N (151.1360922)

6,6-Dimethyl-4-methylene-3-bicyclo[3.1.1]heptanamine

C10H17N (151.1360922)